The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study

Abstract The non-thyroidal illness syndrome (NTIS) is considered a transient and completely reversible phenomenon, but it has been shown that it may last for several days postoperatively after coronary artery bypass grafting (CABG) surgery. This study was undertaken to assess thyroid function 6 months after uncomplicated CABG. The thyroid profile was evaluated in 40 consecutive patients undergoing CABG preoperatively, at 0, 12, 48, and 120h postoperatively, and at 6-month follow-up. Triiodothyronine (T 3), free T 3 (FT 3), free thyroxine (FT 4) and thyroid stimulating hormone (TSH) were assayed using a microparticle enzyme immunoassay. T 4 and total serum thyroid hormone-binding capacity (T-uptake) were measured on the same samples using a fluorescence polarization immunoassay. Patients with severe systemic illness and patients treated with amiodarone were excluded. All patients were euthyroid at admission. Mean age was 67.4±9.0years. There were 31 (77.5%) men. Typical NTIS was observed in all patients, and the FT 3 concentration was still reduced by postoperative day 5 (p<0.0001). At 6-month follow-up, all patients were free from cardiac symptoms, and no new cardiac events were recorded. The thyroid profile was normal in 35 patients (87.5%). One patient (4.5%) had developed overt hypothyroidism. Two patients had isolated low T 3 and FT 3 levels with normal TSH. Two patients had moderately increased FT 3 levels with suppressed TSH. In most uncomplicated patients, thyroid function returns to normal 6months after CABG. However, we observed significant alterations of the thyroid profile in 5 out of 40 patients. Further studies are needed to define the long-term consequences of postoperative NTIS.

[1]  A. Cerillo,et al.  Free triiodothyronine: a novel predictor of postoperative atrial fibrillation. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  U. Paradossi,et al.  Mitral valve repair for degenerative disease: is pericardial posterior annuloplasty a durable option? , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  A. L'Abbate,et al.  Low-T3 Syndrome: A Strong Prognostic Predictor of Death in Patients With Heart Disease , 2003, Circulation.

[4]  A. Cerillo,et al.  Is the low tri-iodothyronine state a crucial factor in determining the outcome of coronary artery bypass patients? Evidence from a clinical pilot study. , 2002, The Journal of endocrinology.

[5]  J. Klemperer Thyroid hormone and cardiac surgery. , 2002, Thyroid : official journal of the American Thyroid Association.

[6]  M. Yap,et al.  Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. , 2000, Metabolism: clinical and experimental.

[7]  J S Child,et al.  Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. , 1998, The American journal of cardiology.

[8]  M. Surks,et al.  Drugs and thyroid function. , 1995, The New England journal of medicine.

[9]  R. Utiger Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? , 1995, The New England journal of medicine.

[10]  N. Burdash,et al.  Cardiopulmonary bypass temperature does not affect postoperative euthyroid sick syndrome? , 1995, Chest.

[11]  M. Hamilton Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. , 1993, The Annals of thoracic surgery.

[12]  T J Wilke,et al.  Estimation of free thyroid hormone concentrations in the clinical laboratory. , 1986, Clinical chemistry.

[13]  A. Cerillo,et al.  Nonthyroidal illness syndrome in off-pump coronary artery bypass grafting. , 2003, The Annals of thoracic surgery.

[14]  L. J. Groot,et al.  Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .